What if you'd held NAUT?
A $1,000 investment in Nautilus Biotechnology, Inc. (NAUT) at the month-end close of 2020-08 would be worth $84.21 at the close of 2026-08 — -91.6% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $2,202.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2020
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2020 | $1,000 | — |
| 2021 | $477 | -52.3% |
| 2022 | $166 | -65.3% |
| 2023 | $276 | +66.1% |
| 2024 | $155 | -43.8% |
| 2025 | $180 | +16.1% |
| 2026 | $83.04 | -53.8% |
Best and worst month-end to buy
The best single month-end close to have bought NAUT was 2025-08 ($0.68): $1,000 then is $1,325 today. The worst was 2021-02 ($15.70): $1,000 then is $57.39.
FAQ
What would $1,000 in NAUT be worth today?
A $1,000 investment in Nautilus Biotechnology, Inc. (NAUT) at the start of 2020 would be worth about $84.21 today, a total return of -91.6%. Dividends are reinvested in these figures.
What were the best and worst years for NAUT?
Nautilus Biotechnology, Inc. (NAUT)'s strongest calendar year since 2020 was 2023, a +66.1% return — $1,000 held through that year became about $1,661 by year-end. Its weakest year was 2022, at -65.3%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in NAUT have grown?
Investing $100 at the end of every month since 2020-08 would have grown to about $2,925 on $7,300 invested.
Did NAUT beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $2,202. NAUT trailed the S&P 500 by +96.2% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Nautilus Biotechnology, Inc. (NAUT) historical total-return data from 2020-08 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.